Dapagliflozin/Metforminklorid Krka

Dapagliflozin/Metformin Krka combines two oral diabetes medications for blood sugar management. This fixed-dose combination may help control glucose levels in adults with type 2 diabetes.

Dapagliflozin/Metformin Krka is typically used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. This combination therapy may be prescribed when metformin alone is not sufficient. The medication works by increasing insulin sensitivity and reducing glucose absorption in the kidneys.

Common effects of Dapagliflozin/Metformin Krka may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when first starting the medication. Some users may also experience increased urination due to the dapagliflozin component. These effects are generally mild and temporary.

Dapagliflozin/Metformin Krka should be used with caution in individuals with kidney problems or a history of pancreatic issues. It is important to stay hydrated while taking this medication. Regular monitoring of blood sugar levels is recommended. Consult a healthcare provider before use.

Dapagliflozin/Metformin Krka may interact with certain medications, including diuretics, corticosteroids, and other diabetes drugs. Alcohol consumption should be limited, as it can affect blood sugar levels. Always inform your healthcare provider about all medications you are taking.